Wanda Health Announces a New Partnership with Florida-based Smart Meter Corp

Wanda Health Inc, a leading telehealth company that provides a virtual care platform for patients with heart failure and other chronic diseases, today announced a partnership with Florida-based Smart Meter Corporation, a cellular-enabled remote monitoring devices provider, to ensure reliable, high quality data capture from patients, regardless of access to smart devices and internet connectivity.

The partnership will provide intelligent virtual care, device logistics, timely alert management and patient engagement services to complement the extensive collection of care management capabilities that comprise the Wanda Health intelligent virtual care platform.  Designed specifically for healthcare providers in North America and Europe, the partnership will give optimal data from cellular-connected devices no matter where they are located.

The growth in the digitally-connected healthcare market has exploded since the beginning of the Covid-19 pandemic, and the type of solutions and services offered by Wanda Health are seeing increased demand on all fronts. Indeed, the global connected healthcare market size is projected to grow from approximately US$51.59 billion in 2021 to approximately US$297.95 billion in 2028*, with market demand exploding across all regions, particularly in North America, Europe, Asia Pacific and elsewhere.

Wanda Health Inc is a portfolio company of EMV Capital, a wholly owned subsidiary of NetScientific PLC. Starting as a UCLA spin-out, Wanda Health’s platform warns healthcare practitioners and patients of potential adverse medical incidents, thus helping identify urgent medical care and treatment needs, and contributing to reduced re-admissions and emergency department visits. This new partnership will boost the company’s offering and provide increased service to those located in remote areas where connectivity can falter.

“Customers demand accuracy and precision in both the quality of the readings and the transmission of that data,” said Casey Pittock, Smart Meter CEO. “The combination of Smart Meter devices and the Wanda Health RPM solution will result in delivering the timely information that will improve care and facilitate billing for remote patient monitoring services.”

“Our partnership with Smart Meter will continue to enhance our intelligent virtual care platform, by increasing access to not only quality but quantity of ingested patient data,” Tom Smith, CEO of Wanda Health said. “This will help us to reach new patient populations and enhance our program offerings to healthcare providers.”

“As part of our trans-Atlantic thesis, our investment in Wanda has helped the company to focus on scaling its connected health offering in the US healthcare market, Dr Ilian Iliev, Managing Director for EMV Capital and CEO for NetScientific PLC noted.  “During COVID this market saw an explosion of demand as digitisation of healthcare services took off. We are pleased to see the results of the team’s work over the last few years, as Wanda moves towards accelerated commercialisation in the US, while exploring growth opportunities in the UK and Europe.”

*Ref: Fortune Business Insights

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version